Frankfurt - Delayed Quote EUR

Spago Nanomedical AB (publ) (7UX.F)

0.0258

+0.0012

(+4.88%)

At close: 3:29 PM GMT+2

Key Events

Advanced Chart

Loading Chart for 7UX.F

9/21 12:03 PM

DELL

Previous Close 0.0246
Open 0.0242
Bid 0.0278 x --
Ask 0.0338 x --
Day's Range 0.0242 - 0.0258
52 Week Range 0.0162 - 0.0564
Volume 12,000
Avg. Volume 0
Market Cap (intraday) 9.868M
Beta (5Y Monthly) 2.05
PE Ratio (TTM) --
EPS (TTM) -0.0300
Earnings Date --
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est --

Spago Nanomedical AB (publ), a clinical phase nanomedicine company, engages in the development of nanomedicines for cancer diagnostics and treatment primarily in Sweden. Its products include SpagoPix (SN132D), an MRI contrast agent, which is under Phase I development stage for the treatment of breast cancer, and under Phase II development stage for the treatment liver and pancreas cancer, as well as offers Tumorad (SN201), a radionuclide therapy for treatment of advanced and metastatic cancer, under Preclinical development stage. The company was formerly known as Spago Imaging AB (publ) and changed its name to Spago Nanomedical AB (publ) in May 2014. Spago Nanomedical AB (publ) was incorporated in 1999 and is based in Lund, Sweden.

spagonanomedical.se